Moonlake Immunotherapeutics (MLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 61,660 | 70,024 | 65,217 | 71,434 | 60,698 |
| Operating Income | -61,660 | -70,024 | -65,217 | -71,434 | -60,698 |
| Interest Expense | 2,632 | 2,269 | 1,995 | 3,198 | 2,037 |
| Other Income | 2,577 | 3,208 | 4,443 | 4,053 | 6,779 |
| Pre-tax Income | -61,715 | -69,085 | -62,769 | -70,579 | -55,956 |
| Income Tax | 90 | 622 | 248 | 115 | 95 |
| Net Income Continuous | -61,805 | -69,707 | -63,017 | -70,694 | -56,051 |
| Minority Interests | N/A | N/A | -592 | -965 | -831 |
| Net Income | $-61,805 | $-69,707 | $-62,425 | $-69,729 | $-55,220 |
| EPS Basic Total Ops | -0.84 | -0.98 | -0.93 | -1.10 | -0.87 |
| EPS Basic Continuous Ops | -0.84 | -0.98 | -0.93 | -1.12 | -0.89 |
| EPS Diluted Total Ops | -0.84 | -0.98 | -0.93 | -1.10 | -0.87 |
| EPS Diluted Continuous Ops | -0.84 | -0.98 | -0.93 | -1.12 | -0.89 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.98 | -0.92 | -1.10 | -0.87 |
| EBITDA(a) | $-60,764 | $-69,179 | $-64,466 | $-70,689 | $-59,956 |